{"version":"1.0","type":"link","title":"Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab.","author_name":"Ullmann M 외","author_url":"https://prs-insight.online/author/Ullmann%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160216","thumbnail_width":1200,"thumbnail_height":630}